Anti-Human IL17A Recombinant Antibody(Bimekizumab)
-
产品编号
YR1328
-
别名
科研级 Bimekizumab ( 比美吉珠单抗 ), Anti-IL17A Recombinant Antibody, Research Grade Bimekizumab
-
规格
- 1mg
- 5mg
产品介绍
| Alias | 科研级 Bimekizumab ( 比美吉珠单抗 ), Anti-IL17A Recombinant Antibody, Research Grade Bimekizumab |
| Catalog Number | YR1328 |
| Molecular Name | Bimekizumab |
| Size | 1mg, 5mg |
| Clonity | Monoclonal |
| Purity | >95% as determined by SDS-PAGE |
| Concentration | 1mg/ml |
| Antibody Isotype | IgG1 Kappa |
| Formulation | PBS, pH7.5 |
| Background | Bimekizumab (INN) is a humanized anti-IL17A and IL-17F monoclonal antibody that is being investigated for ankylosing spondylitis, psoriatic arthritis, and psoriasis. This drug is being developed by Belgian pharmaceutical UCB. As of 2018, bimekizumab is undergoing Phase III trials. |
| CAS Number | 1418205-77-2 |
| Application | ELISA, FCM, IP, FuncS, IF, Neut |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Remarks | This product is for research use only. |
| Shipping Condition | Shipped on ice packs. |
| Target | IL17A[Homo sapiens] |
- 联系我们
- 电话：400-621-6806
- 手机：13116038708
- 邮箱：info@kmdbioscience.com
- 地址：天津市武清区国际企业社区A5号楼
-
销售微信
-
官方公众号
-
400-621-6806 -
614353794 -
周一至周五 9:00-18:00 -
-
0
-
